Cardiovascular safety assessment of febuxostat and allopurinol in the real world: A retrospective cohort study

被引：0
|
作者：
Hung, Pei-Yuan [1 ]
Hsieh, Hui-Hsia [1 ]
Wu, Tien-Yuan [1 ]
Chen, Chi-Hua [1 ]
机构：
[1] Taichung Tzu Chi Hosp, Taichung, Taiwan
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2021年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：159 / 159
页数：1
相关论文
共 50 条
  • [1] Comparing Cardiovascular Safety of Febuxostat and Allopurinol in the Real World: A Population-Based Cohort Study
    Su, Ching-Yen
    Shen, Li-Jiuan
    Hsieh, Song-Chou
    Lin, Lian-Yu
    Lin, Fang-Ju
    [J]. MAYO CLINIC PROCEEDINGS, 2019, 94 (07) : 1147 - 1157
  • [2] Febuxostat vs allopurinol: real-world cardiovascular safety
    [J]. Reactions Weekly, 2019, 1762 (1) : 6 - 6
  • [3] Cardiovascular Safety of Febuxostat Versus Allopurinol in the Real World: Old Reliable Comes Out on Top
    Mankad, Rekha
    [J]. MAYO CLINIC PROCEEDINGS, 2019, 94 (07) : 1128 - 1130
  • [4] A study comparing the safety and efficacy of febuxostat, allopurinol, and benzbromarone in Chinese gout patients: a retrospective cohort study
    Zhou, Qiao
    Su, Jiang
    Zhou, Ting
    Tian, Juan
    Chen, Xixi
    Zhu, Jing
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2017, 55 (02) : 163 - 168
  • [5] Febuxostat or Allopurinol in Patients with Gout Cardiovascular Safety of Febuxostat and Allopurinol in Patients with Gout and Cardiovascular Morbidities (CARES)
    Alten, R.
    Mischkewitz, M.
    Nitschmann, S.
    [J]. INTERNIST, 2020, 61 (05): : 530 - 532
  • [6] Febuxostat vs allopurinol for gout: cardiovascular safety
    [J]. Reactions Weekly, 2021, 1858 (1) : 9 - 9
  • [7] Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout
    White, William B.
    Saag, Kenneth G.
    Becker, Michael A.
    Borer, Jeffrey S.
    Gorelick, Philip B.
    Whelton, Andrew
    Hunt, Barbara
    Castillo, Majin
    Gunawardhana, Lhanoo
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (13): : 1200 - 1210
  • [8] CArdiovascular Safety of Febuxostat and Allopurinol in Patients With Gout and Cardiovascular ComoRbiditiES
    White, William B.
    Chohan, Saima
    Dabholkar, Aruna
    Hunt, Barbara
    Jackson, Robert
    [J]. AMERICAN HEART JOURNAL, 2012, 164 (01) : 14 - 20
  • [9] General Safety of Febuxostat and Allopurinol in a Cardiovascular Outcomes Study in Patients with Gout
    Saag, Kenneth
    Becker, Michael A.
    White, William B.
    Whelton, Andrew
    Borer, Jeffrey
    Gorelick, Philip
    Hunt, Barbara
    Castillo, Majin
    Gunawardhana, Lhanoo
    [J]. ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [10] `Risk of cardiovascular disease associated with febuxostat versus allopurinol use in patients with gout: a retrospective cohort study in Korea
    Hoon Jeong
    Eunmi Choi
    Ahyoung Suh
    Myungsik Yoo
    Bonggi Kim
    [J]. Rheumatology International, 2023, 43 : 265 - 281
12345